Researchers have uncovered a previously unknown contributor to damaging blood vessel formation in the eye, which may lead to new treatments for blinding macular degeneration and other frequent causes of vision loss.
Researchers have discovered a previously unidentified function of "natural killer" (NK) immune cells, which has increased our understanding of how the immune system is controlled to prevent disease.
Researchers at the Fralin Biomedical Research Institute at VTC are looking at potential preventative and therapeutic measures for the disease, optic nerve hypoplasia (ONH), which causes vision impairment in newborns.
Researchers at the Fralin Biomedical Research Institute at VTC are looking at potential preventative and therapeutic measures for the disease, optic nerve hypoplasia (ONH), which causes vision impairment in newborns.
According to a study, patients with thyroid eye disease treated with the minimally invasive insulin-like growth factor I blocking antibody teprotumumab saw improvements in their symptoms, appearance, and quality of life.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.
New Delhi [India], November 30 (ANI/SRV): Aadasat launched an eyecare campaign, which is an extension of the brand's mission to prevent eye disease along with providing eyewear to lakhs of people at the best prices.
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, or advanced heart valve disease, or carotid artery disease associate
Regular use of drugs to lower cholesterol and control type 2 diabetes may lessen the risk of the degenerative eye disease associated with ageing, known as AMD, finds a pooled data analysis of the available evidence, published online in the British Journal of Ophthalmology.
Hyderabad (Telangana) [India], November 3 (ANI/NewsVoir): L V Prasad Eye Institute, a World Health Organization Collaborating Centre for Prevention of Blindness, and CognitiveCare, a Healthcare AI startup and pioneer in the early detection and quantification of health risks, today announced